Role of Siddha medicine in the management of Covid-19 positive patients

Phase 2

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2020/08/027397
• Lead Sponsor: MR SHANMUGASUNDARAM IAS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

S.NoParameter

1.Adult Male/Female subjects above the age of 18 years

2.COVID -19 Positive as determined by RT-PCR

3.Willing to provide written/digital informed consent.

4.COVID - 19 Positive with no clinical signs

5.COVID - 19 Positive with mild symptoms â?? Sneezing, Cough, Sore Throat, Throat Pain, Malaise, Tiredness, Fever, loss of smell, loss of taste

6.COVID - 19 Positive with moderate symptoms â?? Fever with cough, breathlessness but respiratory rate <24 per minute and Oxygen saturation > 95% at rest

Exclusion Criteria

S. NoParameter

1.Pregnant and Lactating females

2.COVID - 19 Positive with Severe symptoms â?? Respiratory distress ( >24 breath per minute), Oxygen saturation < 95% at rest, Respiratory failure, Need of Mechanical Ventilation, Septic shock, Non respiratory organ failure

3.Chronic Renal Failure requiring dialysis (eGFR < 30)

4.Known cases of uncontrolled Diabetes ( >9% HbA1c)

5.Known cases of stage 3 Hypertension ( > 160/100 mmHg)

6.Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening

7.Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc.

8.Subjects taking Steroid treatment and or any kind of immunosuppressive therapy

9.Subjects who are participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.

10. Subjects with bleeding disorders and severe anemia (Hb <7 g/dL)

Study & Design

• Study Type: Interventional
• Study Design: Not specified